The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Leach, M.O., Brindle, K.M., Evelhoch, J.L. et al. (18 more authors) (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. British Journal of Cancer, 92 (9). pp. 1599-1610. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Leach, M.O.
  • Brindle, K.M.
  • Evelhoch, J.L.
  • Griffiths, J.R.
  • Horsman, M.R.
  • Jackson, A.
  • Jayson, G.C.
  • Judson, I.R.
  • Knopp, M.V.
  • Maxwell, R.J.
  • McIntyre, D.
  • Padhani, A.R.
  • Price, P.
  • Rathbone, R.
  • Rustin, G.J.
  • Tofts, P.S.
  • Tozer, G.M.
  • Vennart, W.
  • Waterton, J.C.
  • Williams, S.R.
  • Workmanw, P.
Copyright, Publisher and Additional Information: © 2005 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: biomarker; magnetic resonance; therapeutic trials; antiangiogenic; antivascular; cancer therapy
Dates:
  • Published: 9 May 2005
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 18 May 2017 09:28
Last Modified: 18 May 2017 09:28
Published Version: https://doi.org/10.1038/sj.bjc.6602550
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6602550

Export

Statistics


CORE (COnnecting REpositories)